Jul. 29 at 12:20 PM
$ABCL
$ABCL
partnerships business is one fire right now!
A lot of people may not realize the significance of this
$VRTX
partnership but it’s a bigger signal than the
$JAZZ
partnership.
$VRTX
are very enabled players that make about
$12B a year in revenue. Market cap at
$124B. They don’t just partner with anyone. They are VERY selective. They like what they see.
I think this sentence from Carl Hansen’s letter to shareholders is very fitting:
There are very few examples in our industry, and for every great success story, for every Regeneron or Alnylam or Vertex, there are hundreds, perhaps even thousands, that have tried and failed.
The fact that Vertex is listed as one of the big success stories he highlights says it all.
This officially marks the moment that AbCellera has worked with 10 of the top 20 global biotech companies. I think it’s only a matter of time they join this exclusive club. It may take 20 years but I think they get there.
Good luck to all the longs!
